This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jubilant Organosys Limited. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Akshat Bhatnagar: Innovator in Pharmaceutical Chemistry
Introduction
Akshat Bhatnagar is a notable inventor based in Noida, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes in drug formulation. His work has led to the development of a specific compound that holds promise in the medical field.
Latest Patents
Akshat Bhatnagar holds a patent for a process titled "Process for producing pure form of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine." This patent discloses a method for producing a pure form of the compound by reacting 2-(2-aminoanilino)-5-methylthiophene-3-carbonitrile with N-methyl piperazine, along with N-methylpiperazine acid salt. Additionally, the patent outlines a process for obtaining Polymorphic Form I of the compound through crystallization in a mixture of solvents. Akshat has 1 patent to his name.
Career Highlights
Akshat Bhatnagar is currently employed at Jubilant Organosys Limited, where he continues to work on innovative solutions in pharmaceutical development. His expertise in chemical processes has been instrumental in advancing the company's research initiatives.
Collaborations
Throughout his career, Akshat has collaborated with several professionals in the field, including Jwalant A Shastri and Rajesh Kumar Thaper. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Akshat Bhatnagar is a prominent figure in pharmaceutical chemistry, recognized for his innovative processes and contributions to drug formulation. His work continues to impact the industry positively, showcasing the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile